NMDAR-synprunProject reference: 330284
Funded under :
The roles of juvenile NMDA receptors in synapse maturation and elimination and their association with cognition
Total cost:EUR 166 336,2
EU contribution:EUR 166 336,2
Topic(s):FP7-PEOPLE-2012-IEF - Marie-Curie Action: "Intra-European fellowships for career development"
Call for proposal:FP7-PEOPLE-2012-IEFSee other projects for this call
Funding scheme:MC-IEF - Intra-European Fellowships (IEF)
The aim of the project is to understand how the NMDA receptor subunit NR3A is involved in selective synapse elimination (“pruning”) during development and how the abnormal expression of NR3A found in mental disorders such as Schizophrenia, Alzheimer´s disease and Huntington correlates with the reduction of functional synapses and deficits in the cognitive function. Importantly, the Host lab has already proved that restoring the normal NR3A expression levels reverses both, the spine lost and the cognitive impairment in mouse models. My working hypothesis is that NR3A and its associated signalling complexes act locally as a brake on the maturation of specific synapses to direct targeted, activity-dependent destabilisation and pruning. I will test this hypothesis by: 1) studying mechanisms that underlie the inhibitory effects of NR3A on synapse stabilization or its facilitation of pruning, 2) evaluating how genetic manipulation of NR3A signalling pathways affects cognition. Candidate inhibition/pruning mechanisms that will be tested here include destabilizing effects of NR3A in NMDA receptor mobility within the plasma membrane, altered NMDAR synaptic localization, and recruitment via intracellular domains of NR3A of signalling complexes driving synapse destabilization and disassembly. Specifically, I will use a combination of established and recently developed imaging, molecular biology, electrophysiology and behavioural techniques in primary neuronal cultures, brain slices and the whole animal. The proposed work not only will reveal the molecular links between NR3A expressions, neuronal connectivity and cognitive function in the normal brain, but also will provide and validate suitable targets for the therapeutic intervention in mental disorders where synaptic lost underlies deficits in cognition.
EU contribution: EUR 166 336,2
AVENIDA DE PIO XII 55
Tel.: +34 948194700